NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
08/13/2026
Back to search
Official data from USPTO
HONGENE BIOTECH NUCLEOSIDES & NUCLEOTIDES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
08/13/2026
Trademark type
Combined
Nice classes
1
Filing date
02/26/2019
Registration date
05/12/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
CN
Examiner
LAM, HAI-LY HUYNH
Current location
Historical data usage
Mark description
The mark consists of a stylized key design with a triangular shape formed by the stylized letters "HG" appearing on the bow portion of the key and the wording "NUCLEOSIDES & NUCLEOTIDES" appearing on the stem and the wording "HONGENE BIOTECH" appearing above the stem of the same key design.
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals
Publications
History of USPTO decisions and trademark events.
39 publications found
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
08/13/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/13/2026
71AG
REGISTERED-SEC.71 ACCEPTED
08/13/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2026
E15R
TEAS SECTION 15 RECEIVED
06/17/2026
ES71
TEAS SECTION 71 RECEIVED
05/08/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/12/2025
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/15/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
09/15/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2020
PUBO
PUBLISHED FOR OPPOSITION
02/25/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/21/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/05/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/21/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/21/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/14/2019
GNFR
FINAL REFUSAL E-MAILED
11/14/2019
CNFR
FINAL REFUSAL WRITTEN
11/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2019
RFNT
REFUSAL PROCESSED BY IB
06/22/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/04/2019
RFRR
REFUSAL PROCESSED BY MPU
06/04/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/11/2019
CNRT
NON-FINAL ACTION WRITTEN
05/10/2019
DOCK
ASSIGNED TO EXAMINER
05/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/30/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/24/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/18/2019
Continuous trademark protection
Get notified about every new filing that threatens HONGENE BIOTECH NUCLEOSIDES & NUCLEOTIDES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.